Globe Life (NYSE:GL) Rating Lowered to “In-Line” at Evercore ISI

by · The Cerbat Gem

Globe Life (NYSE:GL – Get Free Report) was downgraded by investment analysts at Evercore ISI from an “outperform” rating to an “in-line” rating in a research note issued on Tuesday. They currently have a $155.00 target price on the stock. Evercore ISI’s target price would suggest a potential upside of 10.31% from the stock’s current price.

A number of other equities research analysts also recently commented on GL. Piper Sandler reiterated an “overweight” rating and issued a $167.00 target price on shares of Globe Life in a research report on Friday, November 21st. Wells Fargo & Company reduced their price objective on Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research note on Friday, October 24th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Globe Life in a report on Monday, December 29th. Keefe, Bruyette & Woods increased their target price on Globe Life from $160.00 to $162.00 and gave the company an “outperform” rating in a research report on Tuesday, October 28th. Finally, Truist Financial raised their target price on shares of Globe Life from $150.00 to $158.00 and gave the company a “buy” rating in a report on Friday, October 24th. Nine analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $166.22.

Get Our Latest Report on Globe Life

Globe Life Price Performance

Shares of NYSE:GL opened at $140.52 on Tuesday. The firm has a market cap of $11.19 billion, a price-to-earnings ratio of 10.18 and a beta of 0.48. The firm has a fifty day moving average price of $135.50 and a 200 day moving average price of $134.90. Globe Life has a fifty-two week low of $109.38 and a fifty-two week high of $147.83. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life (NYSE:GL – Get Free Report) last announced its quarterly earnings results on Wednesday, October 22nd. The company reported $4.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.54 by $0.27. The company had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.52 billion. Globe Life had a net margin of 19.36% and a return on equity of 21.81%. During the same period in the previous year, the firm posted $3.44 EPS. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS and its FY 2025 guidance at 14.400-14.600 EPS. As a group, sell-side analysts expect that Globe Life will post 13.87 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Frank M. Svoboda sold 9,379 shares of the firm’s stock in a transaction dated Tuesday, December 16th. The shares were sold at an average price of $140.43, for a total value of $1,317,092.97. Following the completion of the sale, the chief executive officer owned 35,868 shares in the company, valued at approximately $5,036,943.24. This trade represents a 20.73% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.51% of the company’s stock.

Institutional Trading of Globe Life

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Invesco Ltd. increased its holdings in Globe Life by 3.9% during the 2nd quarter. Invesco Ltd. now owns 3,921,439 shares of the company’s stock worth $487,396,000 after purchasing an additional 147,644 shares during the period. Geode Capital Management LLC raised its holdings in shares of Globe Life by 2.9% in the second quarter. Geode Capital Management LLC now owns 2,722,768 shares of the company’s stock valued at $339,875,000 after acquiring an additional 76,995 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Globe Life by 2.9% in the third quarter. Dimensional Fund Advisors LP now owns 2,076,232 shares of the company’s stock valued at $296,841,000 after acquiring an additional 59,353 shares in the last quarter. AQR Capital Management LLC lifted its stake in Globe Life by 98.6% in the second quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock worth $174,340,000 after acquiring an additional 696,548 shares during the period. Finally, Norges Bank bought a new position in Globe Life during the 2nd quarter worth about $157,722,000. 81.61% of the stock is owned by hedge funds and other institutional investors.

Globe Life Company Profile

(Get Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Further Reading